Digestive tract microbiota

Digestive tract microbiota refers to the diverse community of microorganisms—including bacteria, archaea, fungi, and viruses—residing in the gastrointestinal tract[1][3][7]. This complex ecosystem plays crucial roles in human physiology: it extracts energy from otherwise indigestible food, protects against pathogenic microbes, regulates immune responses, and maintains the integrity of the gut barrier[7][5]. Changes in the composition (dysbiosis) of these microbial populations are associated with metabolic diseases, inflammation, cancer, and neuropsychiatric disorders[6][3]. While the gut microbiota is an important modulator of biological responses and drug efficacy[4], it is not itself a single therapeutic "target" in the conventional sense (i.e., not a receptor, enzyme, or protein); efforts to manipulate it for therapeutic benefit usually involve the administration of probiotics, prebiotics, antibiotics, or targeted microbial enzyme inhibitors[2][4]. Selective manipulation of microbial communities and their metabolic capabilities shows promise for numerous indications, but interventions must navigate significant safety, efficacy, and ecosystem complexity challenges.

Other names

gut microbiotagut floragastrointestinal tract microbiotaintestinal microbiotagastrointestinal floradigestive tract microbiomegut microflora

Modulation of microbiota composition (growth inhibition, selective enrichment); Enzyme inhibition (e.g., blocking bacterial activation of drug metabolites); Metabolite modification (altering SCFA production, bile acid transformations); Immunomodulation via microbial signals